PCSaudits were performed for 29 institutions. Based on the facility survey by Tsunemoto, 13 institutes were classified as A1 (university hospital/cancer centertreating >300 patients/year), 10 as B1 (otherinstitutes>120patients/year) and six as B2 (other institutes <120 patients/year). Medical charts for 455 patients with thoracic esophageal cancer between 1992 and 1994were reviewed based on the data format of PCS in the USA. Results: Concerning external beam equipment, linear accelerators of~1 0 MV were used for 73% of patients in A1, whereas in 81-2, 60CO machines were still used for 13%of patients (P< 0.0001). The median number of full-time equivalent (FTE) radiation oncologists was 2.7 in A1, 0.65 in B1 and 0.2 in B2. Forty-five percent of patients had received surgery in A1 and 34% in 81-2 (P= 0.0068).
INTRODUCTION
Radiation therapy is expected to play an important role in cancer management in the next century because of a rapid increase in the number of elderly patients in Japan. These patients are generally not suitable candidates for aggressive surgery or chemotherapy. In the field of radiation oncology, many innovative techniques such as conformal therapy, intraoperative radiation therapy and heavy ion medical accelerator therapy have been developed by pioneers in Japan. However, basic treatment using photons, which is currently used to treat 99% of the candidates for radiation therapy, is not sophisticated enough. A structure survey of radiation oncology in 1990 by Tsunemoto (1) and a subsequent comparative study between the USA and Japan (2) showed that more than 60% of institutions in Japan were staffed by part-time radiation oncologists and that the structure was immature and still developing.
To improve the quality of radiation oncology throughout Japan, Patterns of Care Study (PCS), a well known QA program for radiation oncology (3) (4) (5) , was introduced in Japan with the strong support of one of the authors, Gerald E. Hanks, Principal Investigator of the original PCS in the USA and Chairman of the Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia. The feasibility of this study in Japan was tested by collecting data by extramural audit for esophageal cancer patients nationwide. In the current study, the effect of institutional stratification, including equipment and personnel, on the process of work-up and treatment was also investigated.
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MATERIALS AND METHODS
Official requests for an extramural PCS audit by Principal Investigators (M.A. and H.I.) of two different cancer research groups supported by the Ministry of Health and Welfare in Japan were mailed to 22 members of four different radiation oncology research groups by this Ministry. Fifteen members (72%) agreed to participate in this audit. Furthermore, the Directors or Chairmen of 14 affiliated hospitals of four academic institutions (Osaka University, Kyoto University, Hiroshima University and Shinshu University) approved PCS audits. From July 1996 through February 1997, audits were performed for 29 institutions ( Table 1) by one of the authors (T.T.) and medical charts and treatment records were reviewed based on the same data format as that of PCS in the USA, which was provided by two of the authors, Gerald E. Hanks and Jean B. Owen, Director of PCS, American College of Radiology, Philadelphia. Actual audits for the survey took -590 h in total. Eligibility criteria were the same as those for PCS in the USA, as follows. Sequence is based on the dates when audits were actually performed. The treatment period was January 1, 1992 to December 31, 1994. The start of treatment refers to radiation therapy, regardless of any treatment which may have preceded it. The patient's treatment should have started during the period under investigation. Stages I, II and ill according to the American Joint Committee on Cancer (AJCC) are eligible, i.e. patients with distant metastasis are ineligible. Squamous, adenosquamous or adenocarcinoma are eligible. Undifferentiated types are ineligible. The tumor must be located in the thoracic esophagus, which means that cervical esophagus cases are ineligible. Gastroesophageal junction cancers are eligible as long as the bulk of the tumor is in the esophagus and not in the stomach. Kamofsky Performance Status (KPS) must be >50 prior to the start of therapy. The patient must not have been diagnosed with any other cancer within the 5 years prior to start of treatment. Non-melanoma skin cancer is excepted. The subject of this study is not the whole population of patients with esophageal carcinoma who visited each institution, but included only those who visited each radiation oncology division.
Japanese institutes of radiation oncology were stratified into four categories according to the facility master survey by Tsunemoto (1) (Table 2 ). Based on this stratification, 13 institutions were classified as Al (university hospital/cancer center treating~300 patients/year), 10 institutions as B1 (other institutions treating~120 patients/year) and six institutions as B2 (other institutions treating <120 patients/year) in the current series. The total number of esophageal cancer patients surveyed was 455.
Statistical significance was tested by means of the chi-squared test.
RESULTS
BACKGROUND
The median age (minimum-maximum) of the patients was 64 years (41-92) for Al institutions and 67 years (36-90) for BI-2 institutions (P = 0.2752). There was no difference in gender ratios between two strata (Table 3 , P =0.1207). The KPS of the patients in A 1 institutions was better than that of B1-2 institutions ( Table   3 , P < 0.0001).
WORK-UP
Histologically, 98% of the patients had squamous cell carcinoma and only 2% had adenocarcinoma in Al institutions. There were no patients with adenocarcinoma and 3% with unknown histology in BI-2 institutions (Table 3 , P = 0.0042). There was a significant difference in AJCC stage distribution between Al and BI-2 institutions (Table 3 , P = 0.0039): more Stage ill patients were found in A1 institutions and more Stage II patients in B1-2 institutions. 
TREATMENT
Forty-fivepercentof the patients had received surgery in the Al and 34% in the Bl-2 institutions (Table 4 , P = 0.0068). In academic institutions (A1),the incidence of combined surgery was higherthan in non-academic institutions (B1-2). External irradiation doses for the non-surgery group are shown in Fig. 1(a) . A radiation dose >60 Gy was delivered to significantly more patients in Al institutions than in Bl-2 institutions (P = 0.0008). Corresponding figures for pre-and postoperative RT groupsare shown in Fig. 1(b) and (c).In the preoperative RT group, doses from 30 to 40 Gy were delivered.
In the postoperative RT group, doses from 40 to 60 Gy were irradiated. There was no significant difference in the dose rangefor either group in the two types of institutions. Brachytherapy was utilized for more patients in Al (16%) than Bl-2 (5%) institutions (Table 4 , P = 0.0001). Combined chemotharapy was more frequently administered to patients in A1 than in B1 institutions (Table 4 , P < 0.0001). Concurrent administration and chemotherapeutic agents such as cisplatin and 5-fluorouracil were also frequently used in both strata of institutions. The number of treatment portalsused per day is shown in Table 4 . All fields were treatedeveryday in more than 75%of thepatients in Al institutions, compared with >55% in Bl-2 institutions (P < 0.0001). 
STRUCTURE INCLUDING EQUIPMENT AND PERSONNEL
External beam equipment for the treatment is shown in Fig. 2 . In A1 institutions,a linear accelerator of~1aMY was used for 80% of patients. However, in B1-2 institutions, 13% of patients were still treated with a 60Co machine (P < 0.0001).The median value (minimum-maximum) of the number of full-time equivalent (PTE) radiation oncologists (40 h/week for radiation oncology service) was 2.7 (1.7-9.3) in AI, 0.65 (0.2-1) in B1 and 0.2 (0.1-0.5) in B2 institutions, as shown in Table 5 . 
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The median age of the patients in A 1 institutions was 3 years younger than those in B1-2 institutions, because there may be a tendency for older patients with lower KPS to be treated in local community hospitals near to their homes or in B1-2 institutions. Therefore, the patients in Al institutions might undergo surgery more frequently. A majority of the patients (>80%) were male. However, in B1-2 institutions the ratio of female patients increased with a higher median age. KPS was markedly lower for the patients in B1-2 than in A 1 institutions. This finding also reflects the higher median age of the patients in the former,
Most patients showed squamous cell histology. Only four patients in A1 institutions had adenocarcinoma. Six patients in B1-2 institutions had clinically apparent esophageal tumors, although no histological description was found on their medical chart. Stage distribution by strata of institution showed a significant difference between A 1 and B1-2 institutions. In type AI, nearly 60% of patients were classified as stage III, compared with 45% in type B1-2. On the other hand, 25% of the patients in A 1 institutions were classified as stage II, compared with 40% in B1-2. InA1 institutions, the median age of the patients in stage II was 63.5 and that in stage III was 64. In B1-2 institutions, corresponding ages were 68 in stage II and 65 in stage III. This suggests that in Al institutions more patients in stage II were referred to surgery and that in B1-2 institutions more stage II patients at an older age were treated with radiation therapy.
The patterns of treatment method by strata showed that in Al institutions surgery was more frequently used than in B1-2 institutions whereas the no-surgery option was more frequently used in B1-2 institutions. This strongly suggests that indication of surgery is also closely related to the strata of institution. Combined chemotherapy was more frequently administered to patients in A1 institutions. In general, larger institutions have more surgeons or medical oncologists to take care of cancer patients during or after aggressive surgery and intensive chemotherapy. Hence in such institutions the indication rate for the non-surgery option, i.e. radiotherapy, for earlier stage patients or the non-chemotherapy option diminishes.
In the non-surgery group, higher doses of 65-70 Gy were delivered for the patients in Al institutions than in BI-2 institutions. Several authors have pointed out that higher doses delivered to the tumor by intracavitary irradiation or accelerated hyperfractionation are required for a better local control rate (6, 7) . The impact of this difference on the outcome should be determined by follow-ups for these patients. Brachytherapy was more frequently applied in Al institutions, reflecting the greater flexibility of treatment options in A1 institutions. The completeness of equipment, especially high dose rate machinery, was closely related to the strata of institution. More than three times the number of patients were treated with a high dose rate machine than those with a low dose rate. Biologically and clinically, parallel opposed fields should be treated each day as summarized in a review by Coia and Hanks (5) . However, in daily clinical practice, this rule has frequently been ignored in Japan, because of a shortage of personnel and limited availability of machine time. This rule was observed in 75% of patients in A 1institutions, but for only 51% in B 1-2 institutions. The distribution of energy of external beam equipment showed that machines with an energy~10 MV were used in Al institutions and that 60Co machines were used for 13% of patients in B 1-2 institutions, so that more satisfactory beam options were available in Al institutions. The number of full-time equivalent radiation oncologists was closely related to the stratification of the institutions, with the personnel for radiation oncology in B1-2 institutions being extremely limited.
This study proved to be feasible in Japan. Detailed information on the process of the work-up and treatment for esophageal cancer patients can be obtained through active collection of accurate data from extramural audits. The stratification of institutions, including equipment and personnel, had a significant influence on several important processes for esophageal cancer patients in this study. This was first demonstrated by the findings Jpn J Clin OncoI1998;28 (5) 313
for radiation oncology practice from original PCS in the USA by Hanks et al. (8) . Sufficient structure will assure better patient care.
To improve the quality of radiation oncology in the whole of Japan, improvement of equipment and personnel is extremely important. This study has great potential for the practical evaluation of how much equipment and personnel will be required, if the relationship between these processes and their outcome can be clearly shown by a future outcome study.
